Evidence-Based Pharmacist Care (Clinical, Economic, and Humanistic Impact): COVID-19

The COVID-19 pandemic posed unparalleled clinical, economic, and humanistic challenges worldwide. Pharmacists emerged as vital healthcare providers, offering multifaceted care encompassing medication management, vaccination, patient education, telehealth, and supply chain coordination. Clinically, pharmacist interventions enhanced therapeutic outcomes, reduced complications, supported disease prevention, and optimized treatment for comorbidities. Economically, pharmacists reduced healthcare expenditures through minimized hospital admissions, ensured cost-effective drug utilization, and facilitated widespread vaccine distribution. Humanistically, pharmacists improved patient quality of life, addressed mental health concerns, promoted medication adherence, and became trusted sources of health information. Despite barriers such as regulatory limitations and misinformation, pharmacists demonstrated adaptability and resilience. Their contributions underscore the essential role of pharmacist-led care in managing pandemics and improving public health outcomes. Strategic integration of pharmacists into healthcare systems is recommended to enhance readiness and response for future global health crises.